The Pentagon’s Defense Advanced Research Projects Agency (DARPA) has issued a pro-solicitation notice for innovative medical therapeutic research proposals in the areas of Soldier Protection and Bio-Defense. DARPA seeks to counter any known, unknown, naturally occurring or engineered pathogen. Proposed research will investigate novel technologies to prevent infection, extend survival until a curative response is available, provide transient immunity, or speed the onset of adaptive immunity. DARPA doesn’t want proposals that are evolutionary or incremental improvements to existing practices. Sol. No. DARPA-BAA-09-43. Respond by June 21, 2010. Contact: Michael Callahan, program manager, [email protected].
free preview